Sponsor

2013/10/31

Kidney International Supplements - Table of Contents alert Volume 3 Issue 3

Kidney International Supplements

Advertisement

Multiplexed Immunoassay Services for Kidney Injury Biomarkers

Myriad RBM provides biomarker services for the early and sensitive detection of kidney damage. Explore the utility of our KidneyMAP® service products and learn how your colleagues have applied our protein biomarker solutions to advance their development projects.

Download the Application Notes


KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease


KDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible: Abbott, Amgen, Bayer Schering Pharma, Belo Foundation, Bristol-Myers Squibb, Chugai Pharmaceutical, Coca-Cola Company, Dole Food Company, Fresenius Medical Care, Genzyme, Hoffmann-LaRoche, International Society of Nephrology, JC Penney, Kyowa Hakko Kirin, NATCO—The Organization for Transplant Professionals, National Kidney Foundation (NKF)-Board of Directors, Novartis, Pharmacosmos, PUMC Pharmaceutical, Robert and Jane Cizik Foundation, Shire, Takeda Pharmaceutical, Transwestern Commercial Services, Vifor Pharma, and Wyeth.

TABLE OF CONTENTS

Volume 3, Issue 3 (November 2013)

In this issue
Preface
Contents
Appendix


Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Nature Publishing Group invites you to visit Stand 638 at the ASN Renal Week from November 5-10 in Atlanta, USA.

Please stop by Stand 638 between November 5th to 10th for complimentary copies of Kidney International, Nature Reviews Nephrology and other Nature Publishing Group journals.

Visit www.nature.com/ki and www.nature.com/nrneph to read current content, sign up for FREE e-alerts or submit your paper.

Preface

Top

Notice

Kidney inter., Suppl. 2013 3: 259; 10.1038/kisup.2013.27

Full Text | PDF

Foreword

Kidney inter., Suppl. 2013 3: 260; 10.1038/kisup.2013.28

Full Text | PDF

Work Group Membership

Kidney inter., Suppl. 2012 3: 261; 10.1038/kisup.2013.29

Full Text | PDF

Abstract

Kidney inter., Suppl. 2013 3: 262; 10.1038/kisup.2013.30

Full Text | PDF

Summary of Recommendation Statements

Kidney inter., Suppl. 2013 3: 263-265; 10.1038/kisup.2013.31

Full Text | PDF

Introduction: The case for updating and context

Kidney inter., Suppl. 2013 3: 266-267; 10.1038/kisup.2013.32

Full Text | PDF

Contents

Top

Chapter 1: Assessment of lipid status in adults with CKD

Kidney inter., Suppl. 2013 3: 268-270; 10.1038/kisup.2013.33

Full Text | PDF

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Kidney inter., Suppl. 2013 3: 271-279; 10.1038/kisup.2013.34

Full Text | PDF

Chapter 3: Assessment of lipid status in children with CKD

Kidney inter., Suppl. 2013 3: 280-281; 10.1038/kisup.2013.35

Full Text | PDF

Chapter 4: Pharmacological cholesterol-lowering treatment in children

Kidney inter., Suppl. 2013 3: 282-283; 10.1038/kisup.2013.36

Full Text | PDF

Chapter 5: Triglyceride-lowering treatment in adults

Kidney inter., Suppl. 2013 3: 284-285; 10.1038/kisup.2013.37

Full Text | PDF

Chapter 6: Triglyceride-lowering treatment in children

Kidney inter., Suppl. 2013 3: 286; 10.1038/kisup.2013.38

Full Text | PDF

Appendix

Top

Methods for guideline development

Kidney inter., Suppl. 2013 3: 287-296; 10.1038/kisup.2013.39

Full Text | PDF

Biographic and disclosure information

Kidney inter., Suppl. 2013 3: 297-301; 10.1038/kisup.2013.40

Full Text | PDF

Acknowledgments

Kidney inter., Suppl. 2013 3: 302; 10.1038/kisup.2013.41

Full Text | PDF

References

Kidney inter., Suppl. 2013 3: 303-305; 10.1038/kisup.2013.42

Full Text | PDF

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Kidney International Supplements. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments:

Post a Comment

Keep a civil tongue.

Label Cloud

Technology (1464) News (793) Military (646) Microsoft (542) Business (487) Software (394) Developer (382) Music (360) Books (357) Audio (316) Government (308) Security (300) Love (262) Apple (242) Storage (236) Dungeons and Dragons (228) Funny (209) Google (194) Cooking (187) Yahoo (186) Mobile (179) Adobe (177) Wishlist (159) AMD (155) Education (151) Drugs (145) Astrology (139) Local (137) Art (134) Investing (127) Shopping (124) Hardware (120) Movies (119) Sports (109) Neatorama (94) Blogger (93) Christian (67) Mozilla (61) Dictionary (59) Science (59) Entertainment (50) Jewelry (50) Pharmacy (50) Weather (48) Video Games (44) Television (36) VoIP (25) meta (23) Holidays (14)

Popular Posts